Marksans Pharma

BSE : 524404 | NSE : MARKSANS

Industry : Pharma Drugs | ISIN : INE750C01026 | FreeFloat : 50.00% | FnO : No | LotSize : N/A


Intellectual Capital (IC)2,356.44
Net Worth (NW)1,115.28
Intrinsic Worth (IW)3,471.72
Market Cap (MC)2,824.26
Economic Value Added-1.05
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)67.88%
IC Gross Margin (EBITDA/IC)16.68%
IC Net Margin (NPT/IC)12.00%
Knowledge Turnover (Sales/IC)0.65
Market to Intrinsic Value (MC/IW)0.81

As OfIntrinsic ValueMarket Price
30 Sep 2021Rs. 84.82Rs. 69.00
6 Dec 2021 ---- Rs. 59.70
1.65     2.76%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : NoSell10 DMA : Rs. 57.31BuyHold
KB > 50% : Yes50 DMA : Rs. 64.84
0 < M2IV < 1 : YesVol-Price trend : Rising

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Dec-18
C
248.37
248.52
36.34
31.31
29.55
25.13
14.76
Mar-19
C
247.41
257.14
25.38
19.11
16.68
9.85
9.78
Jun-19
C
245.03
247.21
34.60
29.86
27.61
22.48
20.40
Sep-19
C
256.40
264.28
41.45
36.47
33.66
25.97
28.72
Dec-19
C
287.65
287.68
47.31
39.98
38.34
29.56
34.15
Mar-20
C
335.35
335.38
69.22
59.60
57.56
42.74
44.04
Jun-20
C
331.15
331.33
70.20
62.95
61.40
49.37
60.55
Sep-20
C
356.47
360.14
86.82
67.83
65.90
50.73
47.33
Dec-20
C
358.36
355.20
87.89
79.31
77.64
58.94
49.85
Mar-21
C
330.20
336.21
101.39
100.05
97.22
79.50
81.52
Jun-21
C
348.96
354.85
83.22
75.75
74.78
62.60
67.96
Sep-21
C
361.20
369.77
68.67
61.28
59.78
46.29
39.72
* C - Consolidated, S - Standalone